Elekta and Philips begin installation of MR-guided linear accelerator at The Netherlands Cancer Institute
Event marks continued progress in global consortium’s effort to improve patient outcomes through real-time clinical imaging and precise treatment deliveryAMSTERDAM, April 18, 2016 – Elekta (EKTA-B.ST), Royal Philips (NYSE:PHG, AEX:PHIA) and The Netherlands Cancer Institute, (NKI, Amsterdam, The Netherlands) today announced the installation of a high-field (1.5 Tesla) MR-guided linear accelerator (MR-linac) system. The Elekta MR-linac is designed to capture high-quality images of tumors and surrounding tissue, allowing physicians to rapidly assess and respond by modifying the radiation